Prasanthi Medarametla

Prasanthi Medarametla is an Academy Research Fellow at the School of Pharmacy, University of Eastern Finland. She obtained her Bachelor’s degree in Pharmaceutical Sciences and a Master’s degree in Pharmacoinformatics from NIPER, India. She then worked as a Project Associate and TATA–CSIR–OSDD Fellow at the Indian Institute of Chemical Technology, Hyderabad.

Prasanthi was a Marie Skłodowska‑Curie Early Stage Researcher in the EU‑MSCA ITN project INTEGRATE (Interdisciplinary Training Network for Validation of Gram‑Negative Antibacterial Targets). She completed her PhD at the University of Eastern Finland, Kuopio, in 2020, where she focused on computational screening of novel antibacterials within the INTEGRATE project.

In 2022, she joined the University of Cambridge as a Postdoctoral Researcher with support from the Postdoc Pooli (Jenny and Antti Wihuri Foundation), gaining expertise in experimental microbiology and structural biology techniques, including cryo‑EM and X‑ray crystallography. She later returned to UEF and worked as a Senior Researcher in the Biopharmacy Department before receiving an Academy Research Fellow position in 2025.

Currently, she leads the AVID (Anti‑Virulence Drug Discovery) research group at UEF and serves as the leader of the NORDFORSK NORD‑AViD consortium.

If you’re interested in Master’s projects or planning to pursue a PhD related to antibacterial protein targets and the mechanisms underlying bacterial virulence, feel free to reach out—I’d be happy to discuss potential opportunities.